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Ko and colleagues recently published predictive factors for pneumonia in patients infected with 
Middle East respiratory syndrome-coronavirus (MERS-CoV) [1].   The differentiation between 
MERS-CoV and non-MERS-CoV was evaluated in few studies with no significant findings [2–
4].  In this study, we review a large cohort of patients who were admitted to one (Prince 
Mohammed bin Abdulaziz Hospital) of the 4 MERS-CoV reference centers under the umbrella 
of the Ministry of Health (MoH) to rule out MERS-CoV with the aim to compare MERS-CoV 
positive patients to non-MERS-COV patients.  Prince Mohammed bin Abdulaziz Hospital 
(PMAH) is referral center for all MERS-CoV patients diagnosed in the central region based in 
Riyadh, Saudi Arabia.  The study included all patients from April 1st 2014 to December 2016. 
MERS-CoV testing was done using nasopharyngeal swabs and tested using real time reverse 
transcriptase PCR as described previously [5].  In this cohort, we compared MERS-CoV patients 
to non-MERS-CoV patients.  The comparison used percentage for categorical data and mean + 
standard deviation (SD) for continuous data.   A p value of < 0.05 was considered significant. 
During the study period, there were a total of 2151 patients who were admitted for evaluation for 
MERS-CoV.  Of those patients, 1856 (86.3%) were non-MERS-CoV, and 295 (13.7%) were 
MERS-CoV patients.  Male gender was 61% among MERS-CoV patients and 53.7% among 
non-MERS-CoV patients (P = 0.019).  There was no difference in the mean age of MERS-CoV 
patients (47.3 + 17.8 years) compared with 554.6 + 22.1 years in the non-MERS-CoV patients. 
Overall, the age group 21-40 and 41-60 years were more common among MERS-CoV patients 
(36.9% vs. 24.4% and 32.9% vs. 22.5%, respectively).  Cough and shortness of breath were less 
common in the MERS-CoV than non-MERS-CoV patients (41.4% vs. 50.3% and 54.2% vs. 
66%).  Healthcare workers represented 14.9% and 2.6% (P = 0.0001) in the MERS-CoV than 
non-MERS-CoV patients, respectively.  The mean WBC count was not significantly lower in 
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MERS-CoV vs. non-MERS-CoV patients (mean 7.47 vs 11.5, P =1).  The case fatality rate was 
significantly lower in the non-MERS-CoV (9.2%) compared with MERS-CoV (20%) (P = 
0.0001).   
This is the largest cohort study of MERS-CoV and non-MERS-CoV patients.  Previously, there 
were three case-control studies of MERS-CoV vs. non-MERS-CoV patients.  The first study 
included 17 MERS-CoV patients and 82 non-MERS-CoV patients with a high mortality rate of 
76% and 15% among MERS-CoV and non-MERS-CoV patients respectively.  The second study 
included 80 MERS-CoV patients and was matched to 159 non-MERS-CoV patients with a 
recorded mortality rate of 10%vs. 4.4%.  A third study from Saudi Arabia included 48 patients 
with MERS-CoV infection and 111 MERS-CoV negative patients.  The study included patients 
from October 2012 to April 2014 and the case fatality rates were 35% and 22% respectively.  
The current study included a larger number of patients spanning a longer duration and the case 
fatality rate was only 20%.   This case fatality rate was different in varioust hospitals and ranged 
from 28.6% to 63.6% [6].  The current study had a case fatality rate that is close to the South 
Korea rate and lower than the overall all rate (38.7%) and the Kingdom-wide rate of 36.5% [7].  
The variability of the case-fatality rates may be related to host factors, co-morbidities, care 
provided and yet unidentified factors [6]. 
Most of the cases of MERS occurred in the healthcare settings [2,8].  The proportion of 
healthcare workers (HCWs) in these outbreaks is variable.  In a study of 70 cases, at least 50% of 
the cases were acquired in the hospital setting [9].  In the 2014 Jeddah outbreak, there were 128 
laboratory-confirmed cases in 14 hospitals between February 17 and April 26, 2014 [10].  Of 
these cases, 33% were primary cases and >60% (including 39 HCWs) were acquired within 
healthcare facilities.  In the current study, HCWs represented 14.9% and 2.6% (P = 0.0001) in 
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the MERS-CoV and non-MERS-CoV patients, respectively.  However, the hospital is a referral 
hospital for all MERS cases in the Riyadh region and thus the finding does not represent the 
transmission within the same hospital.  In conclusion, the case fatality rate was higher in the 
MERS than non-MERS and healthcare workers were more common among MERS patients. 
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Table 1: Comparison of characteristics of non-MERS-CoV and MERS-CoV patients 
  
Non MERS-CoV 
(Number) 
Non-MERS-CoV 
(%) 
MERS-CoV 
(Number) 
MERS-CoV  
(%) P value 
Number 1856 
 
295 
  Male 997 53.7 180 61.0 0.0199 
0-20 116 6.3 8 2.7 0.014 
21-40 453 24.4 109 36.9 0.0001 
41-60 417 22.5 97 32.9 0.0002 
61-80 683 36.8 75 25.4 0.0001 
81-100 187 10.1 6 2.0 0.0001 
Abnormal 
CXR 1170 63.0 182 61.7 0.6505 
Fever 1718 92.6 282 95.6 0.065 
Symptoms 1814 97.7 252 85.4 0.0001 
GI symptoms 228 12.3 32 10.8 0.5638 
SOB 934 50.3 122 41.4 0.0047 
Cough 1225 66.0 160 54.2 0.0001 
Healthcare 
workers 48 2.6 44 14.9 0.0001 
Mechanical 
ventilation 168 9.1 69 23.4 0.0001 
Death 171 9.2 59 20.0 0.0001 
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Table 2: Comparison of the means between non-MERS-CoV and MERS-CoV patients 
 
  Non-MERS-CoV SD MERS-CoV SD P value  
Mean age 54.6 22.1 47.3 17.8 1.0 
WBC 11.5 6.53 7.47 4.31 1.0 
Hgb 125.8 27.1 129.1 25.1 0.037 
Platelet 280 131.4 227 107.7 < 0.0001 
PMN Absolute 14.72 128.0 9.46 65.0 0.29 
 
 
